Marizyme, Inc.
MRZM
$0.0018
-$0.0482-96.40%
| Weiss Ratings | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 9.93 | |||
| Price History | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -96.40% | |||
| 30-Day Total Return | -96.40% | |||
| 60-Day Total Return | -92.80% | |||
| 90-Day Total Return | -96.78% | |||
| Year to Date Total Return | -78.05% | |||
| 1-Year Total Return | -97.43% | |||
| 2-Year Total Return | -99.55% | |||
| 3-Year Total Return | -99.91% | |||
| 5-Year Total Return | -99.91% | |||
| 52-Week High % Change | -98.66% | |||
| 52-Week Low % Change | 5.88% | |||
| Price | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.13 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 07, 2025 | |||
| 52-Week High Price (Date) | Mar 21, 2024 | |||
| Valuation | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 237.23K | |||
| Enterprise Value | 26.83M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.30 | |||
| Earnings Per Share Growth | -85.32% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.38 | |||
| Price/Book (Q) | -0.02 | |||
| Enterprise Value/Revenue (TTM) | 146.22 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -2.27 | |||
| Enterprise Value/EBIT | -2.17 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 131.79M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 561 935 9955 | |||
| Address | 555 Heritage Drive Jupiter, FL 33458 | |||
| Website | www.marizyme.com | |||
| Country | United States | |||
| Year Founded | 2007 | |||
| Profitability | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -6,738.20% | |||
| Profit Margin | -13,383.05% | |||
| Management Effectiveness | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -26.57% | |||
| Return on Equity | -- | |||
| Income Statement | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 183.50K | |||
| Total Revenue (TTM) | 183.50K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 116.10K | |||
| EBITDA (TTM) | -11.82M | |||
| EBIT (TTM) | -12.36M | |||
| Net Income (TTM) | -24.56M | |||
| Net Income Avl. to Common (TTM) | -24.56M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 92.62% | |||
| EPS Diluted (TTM) | -0.30 | |||
| EPS Diluted Growth (Q YOY) | 97.43% | |||
| Balance Sheet | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 63.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 854.60K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -15.54M | |||
| Current Ratio (Q) | 0.029 | |||
| Book Value Per Share (Q) | -$0.12 | |||
| Total Assets (Q) | 21.26M | |||
| Total Current Liabilities (Q) | 29.98M | |||
| Total Debt (Q) | 26.66M | |||
| Total Liabilities (Q) | 36.80M | |||
| Total Common Equity (Q) | -15.54M | |||
| Cash Flow | MRZM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 3.33M | |||
| Net Change in Cash (TTM) | -411.20K | |||
| Levered Free Cash Flow (TTM) | -33.51M | |||
| Cash from Operations (TTM) | -3.74M | |||
